Literature DB >> 3527721

Inhibition of lipopolysaccharide-induced monocyte interleukin 1 secretion by gangliosides.

J M Cavaillon, C Fitting.   

Abstract

Gangliosides known to be potent immunosuppressors are shown to inhibit the secretion of interleukin 1 (IL 1) by human monocytes stimulated with lipopolysaccharide (LPS). The inhibitory activity was observed either with mono-, di- or trisialogangliosides. The inhibition of LPS-induced IL 1 secretion was obtained in the presence of indomethacin, indicating that the ganglioside inhibitory capacity was not due to prostaglandin induction. Indeed the inhibitory activity seems to be mediated by an interaction with LPS molecules, preventing their ability to deliver a signal to monocytes for IL 1 secretion.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3527721     DOI: 10.1002/eji.1830160823

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

1.  Gangliosides inhibit the development from monocytes to dendritic cells.

Authors:  M Wölfl; W Y Batten; C Posovszky; H Bernhard; F Berthold
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

2.  GM1 inhibits amyloid beta-protein-induced cytokine release.

Authors:  T Ariga; R K Yu
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

3.  Synergism between membrane gangliosides and Arg-Gly-Asp-directed glycoprotein receptors in attachment to matrix proteins by melanoma cells.

Authors:  G F Burns; C M Lucas; G W Krissansen; J A Werkmeister; D B Scanlon; R J Simpson; M A Vadas
Journal:  J Cell Biol       Date:  1988-09       Impact factor: 10.539

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.